⌘K

Home/Filings/4/0001181431-12-013026

4//SEC Filing

ENDOLOGIX INC /DE/ 4

Accession 0001181431-12-013026

CIK 0001013606operating

View on SEC.gov Company Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 5:27 PM ET

Size

6.4 KB

Accession

0001181431-12-013026

Insider Transaction Report

Form 4

Period: 2012-02-27

ENDOLOGIX INC /DE/ELGX

ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

10% Owner

Transactions

Sale
Common Stock
2012-02-27$12.67/sh−760,100$9,631,835→ 4,694,028 total
Sale
Common Stock
2012-02-28$13.18/sh−489,900$6,455,951→ 4,204,128 total

Footnotes (2)

[F1]Price range of $12.5400 to $12.9590
[F2]Price range of $12.9000 to $13.4150

Documents

1 file

4
rrd336603.xmlPrimary
FORM 4

Issuer

ENDOLOGIX INC /DE/

CIK 0001013606

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001013606

Filing Metadata

Form type: 4
Filed: Feb 28, 7:00 PM ET
Accepted: Feb 29, 5:27 PM ET
Size: 6.4 KB

View on SEC.gov